Although a large proportion of COVID-19 patients recovers fully from the disease, approximately 5% to 10% experience prolonged symptoms for several months following the acute COVID-19 phase [2–4]. This results in millions of people suffering from COVID-19 sequelae worldwide. Therefore, beneficial interventions are urgently needed to counteract these long-term consequences. A Cochrane review from April 2021 identified more than 50 studies that investigated rehabilitative interventions in post-COVID patients [5]. Amongst them are two randomized, controlled trials that included 72 and 140 post-acute patients, respectively, showing that respiratory techniques have superior benefits beyond natural recovery to improve pulmonary function, exercise performance, quality of life, and anxiety, especially in combination with group psychological interventions [6, 7]. However, we admit, that there is currently no randomized, controlled trial available that investigated the effects of a more comprehensive, multidisciplinary pulmonary rehabilitation (PR) program in COVID-19.